Oasis Diagnostics Corporation is structured around supplying of high-quality saliva based diagnostic tests and saliva collection tools, genomic assays, and ELISA microplate assays: non-invasive saliva based technology for rapid testing, sample collection, and molecular diagnostics with application in early detection of diseases and medical disorders, utilizing non-invasive test specimens particularly oral fluids (saliva) and whole blood. The firm specializes in the development of saliva collection tools to includes an array of devices for the standardized collection of oral fluids and testing of specimens both in the laboratory and at the point-of-care. The firm offers VersiSAL® and SuperSAL Saliva Collection Devices for standardized oral fluid collection, VerOFy®, a rapid point-of-care testing platform device, DNASAL, a novel collection tool for the harvesting of DNA from saliva for applications such as PCR, genotyping and genome-wide association studies, DrugSAL, a tool for collection of saliva for abused drug testing and RNAProSAL, a brand new device for the simple and non-invasive collection of RNA and proteins. Thefirm is also the exclusive representative for genomic products from ViennaLab Diagnostics (Vienna, Austria), in North America and distributes products on behalf of Operon S.A. (Zaragoza, Spain) in the United States. The firm also holds exclusive licenses to technologies for the collection and subsequent testing of saliva for Alzheimer's disease, Parkinson's disease and tuberculosis.
